Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (9): 936-939.doi: 10.11958/20231979

• Clinical Research • Previous Articles     Next Articles

Clinical efficacy of 1 565 nm non-ablative fractional laser in androgenetic alopecia

CHENG Yi(), XU Yaping, LYU Lijing, CUI Yu, ZHANG Yan, HU Caixia()   

  1. Department of Dermatology, the Forth Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Received:2024-01-02 Revised:2024-04-10 Published:2024-09-15 Online:2024-09-06
  • Contact: E-mail:48201485@hebmu.edu.cn

Abstract:

Objective To investigate the clinical efficacy and safety of 1 565 nm non-ablative fractional laser combined with topical minoxidil and oral finasteride in the treatment of patients with androgenetic alopecia (AGA). Methods Seventy-five male AGA patients with Norwood-Hamilton classification grade Ⅱ-Ⅲ, were randomly assigned into three groups: the control group 1, the control group 2 and the experimental group, with 25 cases in each group. Patients in the control group 1 received topical 5% minoxidil (1 mL, twice daily). Patients in the control group 2 were treated with both topical 5% minoxidil and oral finasteride (1 mg, once daily). Patients in the experimental group received a combined therapy of 1 565 nm non-ablative fractional laser in addition to topical 5% minoxidil and oral finasteride. Hair overall efficacy was evaluated using a 7-point rating scale after 24 weeks of treatment. Hair diameter and density were measured using a dermoscope. Patient satisfaction was assessed post-treatment, and adverse reactions were recorded. Results The overall efficacy of hair in the experimental group was superior to the control group 1 and the control group 2. There were no significant differences in hair density and hair diameter before treatment between the three groups (P>0.05). After treatment, hair diameter and density increased in all three groups compared to baseline values (P<0.05), and the hair diameter and hair density of the experimental group were higher than those of the control group 1 and the control group 2 (P<0.05). Patient satisfaction in the experimental group was higher than that in the control group 1 and the control group 2 (P<0.05). Patients in the experimental group experienced tolerable pain and burning sensations during laser treatment, and the symptoms were self-alleviated within a few hours. There were no serious adverse reactions reported in any group. Conclusion The combination therapy of 1 565 nm non-ablative fractional laser, 5% minoxidil, and finasteride demonstrates significantly better efficacy in the treatment of AGA than minoxidil and finasteride alone drug therapy.

Key words: alopecia, minoxidil, finasteride, fractional laser, androgenic alopecia, dermal papilla

CLC Number: